Grünenthal GmbH

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 23 Feb 2017
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

350,000€

Financial year: Jan 2015 - Dec 2015

Lobbyists (Full time equivalent)

0.75 Fte (2)

Lobbyists with EP accreditation

2

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Grünenthal GmbH   (Grünenthal)

    EU Transparency Register

    67826544528-01 First registered on 14 Nov 2010

    Goals / Remit

    The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets.

    Grünenthal is one of five remaining research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development. Research and development costs amounted to about 19 percent of revenues in 2015. Grünenthal's research and development strategy concentrates on selected fields of therapy and state-of-the-art technologies. We are intensely focused on discovering new ways to treat pain better and more effectively, with fewer side-effects than current therapies.

    Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Australia, Latin America and the US. Grünenthal products are sold in more than 155 countries and currently approx. 5.400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of 1.212 Mio €

    More information: www.grunenthal.com

    Main EU files targeted

    Grünenthal interests in Brussels deal with issues related to health- and pain care, pharmaceuticals, innovation, research and intellectual property.

    Address

    Head Office
    Zieglerstraße, 6
    Aachen D-52099
    GERMANY
  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    50%1
    25%1

    Lobbyists (Full time equivalent)

    0.75

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    2 accreditations were / are live (in bold) for the selected state of 23 Feb 2017

    Name Start date End Date
    Ms Gudula Maria Petersen 14 Jun 2018 14 Jun 2019
    Mr Theodorus Norbertus Maria van Rooij 17 Oct 2017 17 Oct 2018
    Ms Gudula Maria Petersen 12 May 2017 09 May 2018
    Mr Theodorus Norbertus Maria van Rooij 10 Oct 2016 05 Oct 2017
    Ms Gudula Maria Petersen 29 Apr 2016 29 Apr 2017
    Mr Theodorus Norbertus Maria van Rooij 24 Sep 2015 19 Sep 2016
    Mr Konrad Labuschagne 21 May 2014 05 Jun 2015
    Mr Konrad Labuschagne 25 May 2013 21 May 2014
    Mrs Kristina Barinka 02 Mar 2013 29 Mar 2014
    Mr Konrad Labuschagne 19 Jun 2012 17 Jun 2013
    Mr Theodorus Norbertus Maria van Rooij 24 Mar 2012 01 Dec 2012
    Mrs Kristina Barinka 24 Mar 2012 01 Dec 2012

    Complementary Information

    None declared

    Person in charge of EU relations

    Mr Norbert van Rooij (Governmental Affairs and Health Policy)

    Person with legal responsibility

    Mr Gabriel Baertschi (Chairman of the Corporate Executive Board)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    - Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA): http://www.efpia.eu

    - Grünenthal supports the platform the Societal Impact of Pain (SIP). More info can be found here: https://www.sip-platform.eu

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2015 - Dec 2015

    Lobbying costs for closed financial year

    350,000€

    Other financial info

    This estimate is based on a percentage of the salaries of the staffers in 2015 falling under the scope of the Register, based on the proportion of employee time spent on these activities.
    Furthermore we have included consultancy costs, member association fees and support of health policy related activities in Brussels..

  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    None foreseen

    Other activities

    May 23 2016 Grünenthal was one of the organising partner in the Symposium “Societal Impact of Pain” (SIP) 2016: “Time for action”. The Worksgroup meetings of this sympsoium took place in the European Parliament (https://www.sip-platform.eu/events/sip-2016/program.html )

  • Meetings

    Meetings

    None declared

Download this datacard